Optimi Health Corp.
Research Optimi Health Corp. (OPTH) on Bullrun: market cap USD 19.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOPTH
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 19.35M
- Financial periodQ2 2026
- RevenueUSD 140.20K
- Net income-USD 2.40M
- Free cash flow-USD 2.87M
- Gross margin47.5%
Valuation Snapshot
latest market cap is USD 19.35M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 426.30K | -USD 3.71M | -USD 2.72M | -16.0% | -1.2 | USD 1.15M | USD 6.52M | USD 6.57M |
| FY2024 | USD 389.85K | -USD 6.04M | -USD 4.43M | 69.5% | -2.1 | USD 103.66K | USD 2.75M | USD 9.58M |
| FY2023 | USD 181.09K | -USD 5.19M | -USD 4.41M | 110.6% | -1.8 | USD 1.34M | USD 1.71M | USD 13.21M |
| FY2022 | USD 80.72K | -USD 7.35M | -USD 11.73M | 66.8% | -2.7 | USD 1.89M | USD 157.58K | USD 16.02M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 19.35M | n/a | n/a | n/a |
About Optimi Health Corp.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Optimi Health Corp.'s market cap?
Optimi Health Corp.'s market capitalization is USD 19.35M.
What does Optimi Health Corp. do?
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.